Abivax - ADR
ABVX
Get informed when a big investor buys or sells
+ FollowMarket Cap$6.39B
Close$
$7.71
92.1% downside
Current Fair Value
92.1% downsideOvervalued by 92.1% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $6.39 Billion |
|---|---|
| Enterprise Value | $5.91 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-4.65 |
| Beta | -0.2 |
| Outstanding Shares | 69,527,315 |
Return
| Return on Equity | -90.32% |
|---|---|
| Return on Assets | -70.36% |
| Return on Invested Capital | -62.80% |
Valuation & Multiples
| P/E Ratio | -17.49 |
|---|---|
| PEG | -4.74 |
| Price to Sales | - |
| Price to Book Ratio | 16.25 |
| Enterprise Value to Revenue | 1094.97 |
| Enterprise Value to EBIT | -18.06 |
| Enterprise Value to Net Income | -15 |
| Total Debt to Enterprise | 0.01 |
| Debt to Equity | 0.07 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
June 1, 2026
EPS Estimate
$-0.92
Average shareholder expectationRevenue Estimate
$602,961
Average shareholder expectationNext Earnings Call
Expected Date
September 14, 2026
EPS Estimate
$-0.83
Average shareholder expectationRevenue Estimate
$785,794
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.5978▼ 5.27% |
|---|---|
| Total Calls | 1,849,983▼ 22.05% |
| Total Puts | 1,105,853▼ 28.37% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 71.97%▼ 16.83% |
|---|---|
| Total Invested | $5.53B▼ 27.28% |
| Investors Holding | 285▲ 11.00% |
ESG Score
No data